Beta Drugs (India) Analysis
| BETA Stock | 1,682 38.15 2.22% |
Beta Drugs is overvalued with Real Value of 1467.63 and Hype Value of 1682.0. The main objective of Beta Drugs stock analysis is to determine its intrinsic value, which is an estimate of what Beta Drugs is worth, separate from its market price. There are two main types of Beta Drugs' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Beta Drugs' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Beta Drugs' stock to identify patterns and trends that may indicate its future price movements.
The Beta Drugs stock is traded in India on National Stock Exchange of India, with the market opening at 09:15:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in India. Beta Drugs is usually not traded on Republic Day, Saheb Ambedkar Jayanti Day, Good Friday. Beta Stock trading window is adjusted to Asia/Calcutta timezone.
Beta |
Beta Stock Analysis Notes
The company had not issued any dividends in recent years. Beta Drugs had 20:21 split on the 25th of March 2025.Beta Drugs Investment Alerts
| Beta Drugs generated a negative expected return over the last 90 days |
Beta Drugs Thematic Classifications
In addition to having Beta Drugs stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Technical Drivers
As of the 20th of July, Beta Drugs shows the Risk Adjusted Performance of (0.03), standard deviation of 2.22, and Mean Deviation of 1.63. Our technical analysis interface gives you tools to check existing technical drivers of Beta Drugs, as well as the relationship between them. Please confirm Beta Drugs mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Beta Drugs is priced correctly, providing market reflects its regular price of 1682.0 per share.Beta Drugs Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Beta Drugs for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Beta Drugs short-term fluctuations and highlight longer-term trends or cycles.
Beta Drugs Predictive Daily Indicators
Beta Drugs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Beta Drugs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0347 | |||
| Daily Balance Of Power | (0.64) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 1680.3 | |||
| Day Typical Price | 1680.87 | |||
| Market Facilitation Index | 59.4 | |||
| Price Action Indicator | (17.37) | |||
| Period Momentum Indicator | (38.15) | |||
| Relative Strength Index | 53.08 |
Beta Drugs Forecast Models
Beta Drugs' time-series forecasting models are one of many Beta Drugs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Beta Drugs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Beta Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Beta Drugs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Beta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Beta Drugs. By using and applying Beta Stock analysis, traders can create a robust methodology for identifying Beta entry and exit points for their positions.
Beta Drugs is entity of India. It is traded as Stock on NSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Beta Drugs to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.